News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.176d agobullish
Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority ReviewMT Newswires184d agoneutral
Gilead Sciences' Increased Yeztugo Guidance is 'Good Enough' for the Stock, Morgan Stanley SaysBarrons.com185d agobearish
Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?